In the context of food-seeking behaviors, GLP-1 administration has been shown to decrease mesolimbic dopaminergic signaling [152]
With targeted peptide protocols, we can help support your bodys ability to burn fat, build lean muscle, improve recovery, regulate hormones, and more
Glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors and risk of nonalcoholic fatty liver disease among patients with type 2 diabetes
PLoS Genet 1: e36
Im a 61-year-old with an active lifestyle, you guys are rockin it
Observed side effects in research environments are generally mild and temporary, most commonly including: Temporary fatigue-related observations Mild fluid-retention variability Increased hunger- or appetite-related observations Mild headache-related observations Minor administration-site irritation such as redness or temporary administration-site sensitivity observations Proper reconstitution, sterile handling practices, proper administration techniques, and regular administration-site rotation are important for minimizing local irritation and maintaining peptide stability and consistency during research use